Viome and Scripps Research Develop At-Home RNA Test for Colon Cancer Prevention

July 15, 2025
Viome Life Sciences and Scripps Research have partnered to create the first at-home RNA screening test aimed at detecting precancerous colon polyps, as announced in a press release. The test seeks to enhance colorectal cancer prevention by identifying molecular signals of polyps.

Viome Life Sciences and Scripps Research have announced a strategic partnership to develop the first at-home RNA screening test designed to detect precancerous colon polyps, announced in a press release. This initiative aims to enhance colorectal cancer prevention by identifying molecular signals of polyps, offering improved sensitivity over existing at-home DNA tests.

The collaboration will involve a 1,000-patient clinical study, utilizing RNA-based stool and saliva tests to detect early warning signs of colorectal cancer. The study will leverage Viome's RNA sequencing and AI platform, combined with Scripps Research's clinical expertise, to train the system in identifying early molecular signs of polyp development.

The study will be conducted with patients undergoing routine colonoscopies at Scripps Health, where RNA data will be collected and analyzed to train predictive models. The goal is to develop a diagnostic test that can identify individuals at high risk of developing cancer without the need for invasive procedures. Upon successful validation, Viome plans to pursue a laboratory-developed test for distribution through licensed physicians.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

AI and the Law: Discussion Paper

This discussion paper explores the intersection of artificial intelligence and legal frameworks, addressing potential legal challenges posed by AI's autonomy, adaptiveness, and opacity. It examines issues such as liability gaps, causation, and the potential for granting AI systems legal personality, aiming to foster further discussion on AI's impact on law reform.

Read more